>
>
Stomach Cancer Treatment Market - By Type (Chemotherapy, Immunotherapy), Indication (Gastric Cancer, Gastrointestinal Stomal Tumor), Drug Class (HER2 Antagonists), Route of Administration, Distribution Channel– Global Forecast 2024 – 2032
Download Free PDF

Stomach Cancer Treatment Market
Get a free sample of this reportGet a free sample of this report Stomach Cancer Treatment Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 15
Tables & Figures: 341
Countries covered: 23
Pages: 281
Download Free PDF
Stomach Cancer Treatment Market Size
Stomach cancer treatment market size was valued at around USD 4.7 billion in 2023 and is estimated to grow at 13.5% CAGR from 2024 to 2032. Stomach cancer, also known as gastric cancer, is a type of cancer that begins in the stomach's lining. Treatment options include surgery (partial or total gastrectomy and lymphadenectomy), radiation therapy, chemotherapy, targeted therapy, and immunotherapy. Palliative care is also essential for managing symptoms in advanced stages.
The rising incidence of stomach cancer is a significant driver for the market. For instance, according to World Cancer Research Fund International, the stomach cancer was the fifth most common cancer globally in 2022. It ranked as the fourth most common cancer in men and the seventh in women. Moreover, there were over 968,784 new cases of stomach cancer reported worldwide in 2022. Therefore, this underscores the critical need for advanced diagnostic and treatment solutions to address the growing prevalence of stomach cancer and improve patient outcomes.
Furthermore, advancements in diagnostic techniques, development of targeted therapies, rising awareness and screening programs, are the factors promoting the growth of the market.
Stomach Cancer Treatment Market Trends
Advancements in diagnostic techniques for stomach cancer have revolutionized the treatment landscape, offering profound benefits in early detection, personalized medicine, and treatment efficacy. These innovations are crucial as stomach cancer ranks among the most prevalent cancers globally, with significant implications for public health and patient outcomes.
Stomach Cancer Treatment Market Analysis
Based on type, the market is divided into chemotherapy, immunotherapy, and targeted therapy. The chemotherapy segment of the market is forecasted to reach USD 8.1 billion by 2032.
Based on indication, the stomach cancer treatment market is segmented into gastric cancer /gastroesophageal junction cancer and gastrointestinal stromal tumors. The gastric cancer/ gastroesophageal junction cancer segment accounted for USD 3.3 billion in 2023.
Based on drug class, the stomach cancer treatment market is divided into PD-1/PD-L1 inhibitors, HER2 antagonists, VEGFR2 antagonists, and other drug classes. The PD-1/PD-L1 inhibitors of the market is forecasted to reach USD 5.6 billion by 2032.
Based on route of administration, the stomach cancer treatment market is segmented into oral and injectable. The injectable segment accounted for USD 3 billion in 2023.
Based on distribution channel, the stomach cancer treatment market is bifurcated into hospital pharmacies, specialty & retail pharmacies, and other distribution channels. The hospital pharmacies segment is forecasted to reach USD 7.5 billion by 2032.
The growth of the stomach cancer treatment market in the U.S. is projected to reach USD 5.3 billion by 2032.
The stomach cancer treatment market in UK is expected to experience significant and promising growth from 2024 to 2032.
Japan stomach cancer treatment market is anticipated to witness lucrative growth between 2024 – 2032.
The stomach cancer treatment market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.
Stomach Cancer Treatment Market Share
The stomach cancer therapeutics sector is highly competitive, featuring a mix of major global companies and smaller to medium-sized companies striving for market share. A crucial element of market strategy is the continuous introduction of innovative products utilizing diverse technologies. Leading industry players hold significant influence in this dynamic landscape, often driving advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are vital for strengthening market positions and expanding global footprints amid evolving regulatory landscapes.
Stomach Cancer Treatment Market Companies
Some of the eminent market participants operating in the stomach cancer treatment industry include:
Stomach Cancer Treatment Industry News:
The stomach cancer treatment market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Type
Market, By Indication
Market, By Drug Class
Market, By Route of Administration
Market, By Distribution Channel
The above information is provided for the following regions and countries: